Bertrand Loy

Bertrand Loy, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Entegris Inc, Harvard Bioscience Inc and ITT Inc. The record holds 42 filings, for trades running from 4 January 2016 to 1 August 2026.

Market trades split into 4 purchases (€107k) and 5 sales (€11.2M). Netting one side against the other leaves €11.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 26 share grants and 6 option exercises. 2026 to date brings no purchases and 2 sales.

In size, the median ticket on the buying side is €24k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 4 August 2026, the filings show a share grant in ITT Inc. The last insider purchase was made public on 29 August 2022, 1,511 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.